Literature DB >> 2589448

Immunohistochemical expression of TAG-72 in normal and malignant endometrium: correlation of antigen expression with estrogen receptor and progesterone receptor levels.

A P Soisson1, A Berchuck, B A Lessey, J T Soper, D L Clarke-Pearson, K S McCarty, R C Bast.   

Abstract

TAG-72 is a tumor-associated antigen that is expressed by secretory endometrium and most endometrial adenocarcinomas. We used immunohistochemical techniques to quantitate expression of TAG-72, estrogen receptor, and progesterone receptor in 21 normal endometria and 44 endometrial adenocarcinomas. In normal cycling endometrial glands, TAG-72 expression was related inversely to expression of receptors for estrogen and progesterone. This suggests that TAG-72 expression in normal endometrium may be hormonally regulated. Ninety-one percent of endometrial adenocarcinomas expressed immunohistochemically detectable TAG-72. The magnitude of TAG-72 expression did not correlate with other known prognostic factors in endometrial cancer such as histologic grade, depth of myometrial invasion, surgical stage, or steroid receptor status. The production of TAG-72 by most endometrial adenocarcinomas may represent nonspecific expression by cells that have dedifferentiated.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2589448     DOI: 10.1016/0002-9378(89)90678-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

1.  Improved targeting of an anti-TAG-72 antibody drug conjugate for the treatment of ovarian cancer.

Authors:  Megan Minnix; Lin Li; Paul Yazaki; Junie Chea; Erasmus Poku; David Colcher; John E Shively
Journal:  Cancer Med       Date:  2020-05-05       Impact factor: 4.452

2.  MiR-32-3p Regulates Myocardial Injury Induced by Microembolism and Microvascular Obstruction by Targeting RNF13 to Regulate the Stability of Atherosclerotic Plaques.

Authors:  Dajun Huang; Yang Liu; Le Gao; Xiaomin Wei; Yuli Xu; Ruping Cai; Qiang Su
Journal:  J Cardiovasc Transl Res       Date:  2021-06-29       Impact factor: 4.132

Review 3.  The expansion of targetable biomarkers for CAR T cell therapy.

Authors:  Michelle H Townsend; Gajendra Shrestha; Richard A Robison; Kim L O'Neill
Journal:  J Exp Clin Cancer Res       Date:  2018-07-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.